Cargando…
Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
Autores principales: | Cavelti-Weder, Claudia, Muggli, Bettina, Keller, Cornelia, Babians-Brunner, Andrea, Biason-Lauber, Anna, Donath, Marc Y., Schmid-Grendelmeier, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357226/ https://www.ncbi.nlm.nih.gov/pubmed/22619293 http://dx.doi.org/10.2337/dc12-0115 |
Ejemplares similares
-
Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes
por: Cavelti-Weder, Claudia, et al.
Publicado: (2011) -
Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine
por: Yanai, Hidekatsu, et al.
Publicado: (2011) -
Insulin Concerns and Promises
por: Bloomgarden, Zachary T.
Publicado: (2011) -
Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011) -
A Case of Insulin-Dependent Diabetes Associated With Enteroviral Infections
por: Hamasaki, Hidetaka, et al.
Publicado: (2012)